Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model

Antimicrob Agents Chemother. 2013 May;57(5):2365-8. doi: 10.1128/AAC.02288-12. Epub 2013 Feb 12.

Abstract

This study addresses the effects of micafungin, caspofungin, and anidulafungin against Candida albicans biofilms developed in a subcutaneous catheter rat model system. Doses of 5, 10, and 30 mg/kg (of body weight)/day (the last only for micafungin) were given intravenously for 5, 7, and 10 days. All three echinocandins caused a significant reduction of the Candida cell numbers on the implanted catheters and are thus promising for the treatment of biofilm-related infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology*
  • Biofilms / drug effects*
  • Biofilms / growth & development
  • Candida albicans / drug effects*
  • Candida albicans / growth & development
  • Candidiasis / drug therapy*
  • Candidiasis / microbiology
  • Catheters, Indwelling / microbiology
  • Dermatologic Surgical Procedures
  • Echinocandins / pharmacology*
  • Female
  • Injections, Intravenous
  • Rats
  • Rats, Sprague-Dawley
  • Skin / drug effects*
  • Skin / microbiology

Substances

  • Antifungal Agents
  • Echinocandins